SGSM1 as a pan-cancer biomarker: multi-omics insights into immune regulation, prognostic value, and therapeutic implications
Abstract Background It has been shown that the protein known as Small G Protein Signaling Modulator 1 (SGSM1), which has both a TBC domain and RUN domain and was linked to RAB- and RAP-mediated cellular signaling, is involved in the advancement of tumors. It is unclear, however, whether SGSM1 is piv...
Saved in:
| Main Authors: | Dali Wu, Guanghui Zhong, Yufeng Liu, Cuilian Li, Lingfei Yan, Yang Luo, Qing Li, Dawei Liu, Tao Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-06-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02940-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SPECC1 as a pan-cancer biomarker: unraveling its role in drug sensitivity and resistance mechanisms
by: Dongwei Liu, et al.
Published: (2024-10-01) -
Comprehensive multi-omics pan-cancer analysis revealed EGFLAM as a potential prognostic and immune infiltration-associated biomarker
by: Jian Yang, et al.
Published: (2025-07-01) -
eQTL and multi-omics integration reveal PPIH as a prognostic and immunotherapeutic biomarker
by: Fenglin Lv, et al.
Published: (2025-08-01) -
Identification of DCAF5 as a novel cancer prognostic and immunotherapy biomarker through pan-cancer analysis and renal clear cell carcinoma clinical data validation
by: Huaqing Yan, et al.
Published: (2025-06-01) -
NOX4 as an emerging prognostic and immunological biomarker across pan-cancer analyses
by: Yusheng Liu, et al.
Published: (2025-05-01)